Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
All Cause Mortality
11%
Allergic Asthma
50%
Allergic Disease
10%
Allergy
10%
anthra[1,9 Cd]pyrazol 6(2h) One
10%
Antiallergic Drug
50%
Antiinflammatory Activity
10%
Capecitabine
23%
Chemotherapy Regimens
100%
Colorectal Carcinoma
50%
Combination Therapy
7%
Cytokine
10%
Dysbiosis
13%
Eosinophilia
10%
Fluorouracil
11%
Histamine
10%
Immune Checkpoint Inhibitor
50%
Immunoglobulin E
50%
Interleukin 13
20%
Interleukin 4
20%
Interleukin 5
10%
Interleukin 6
20%
Isoquinoline Alkaloid
10%
Liver Cell Carcinoma
13%
Lung Disease
10%
Melanoma
13%
Non Small Cell Lung Cancer
13%
Oral Administration
10%
Ovalbumin
50%
Overall Survival
17%
Phosphotransferase
10%
Phosphotransferase Inhibitor
10%
Progression Free Survival
17%
Prostaglandin D2
20%
Proton Pump Inhibitor
100%
Random Effects Model
8%
Receptor
10%
Renal Cell Carcinoma
13%
Respiratory Tract Allergy
10%
Respiratory Tract Inflammation
10%
Squamous Cell Carcinoma
13%
Transitional Cell Carcinoma
13%
Tumor Necrosis Factor
10%
Immunology and Microbiology
Airway
10%
Allergic Asthma
50%
Allergic Disease
10%
Allergy
10%
Amino Terminal Sequence
20%
Antiinflammatory Activity
10%
Body Weight
10%
Bone Marrow Derived Mast Cell
20%
Bronchoalveolar Lavage Fluid
20%
CD4
10%
Cell Activation
50%
Degranulation
20%
Histamine
10%
Immunoglobulin E
50%
Inflammation
10%
Inflammatory Cell
10%
Inflammatory Cytokine
10%
Interleukin 13
20%
Interleukin 4
20%
Interleukin 5
10%
Interleukin 6
20%
Kinase
20%
Lung
10%
Mast Cell
50%
Mediator
10%
Phosphotransferase
20%
Prostaglandin D2
20%
Receptor Affinity
10%
Respiratory Tract Allergy
10%
Signal Transduction
10%
T Cell
10%
Tumor Necrosis Factor
10%
Nursing and Health Professions
All Cause Mortality
11%
Capecitabine
23%
Chemotherapy
50%
Colorectal Carcinoma
50%
Combination Therapy
7%
Fluorouracil
11%
Medline
7%
Proton Pump Inhibitor
50%
Systematic Review with Meta-Analysis
50%
